Free Float 77,58 %
Shares Float 135,51 M
Shares Outstanding 174,66 M
INTELGENX TECHNOLOGIES
Share · US45822R1014 · A0RP0X (XTSX)
No Price
n/a
Share Float & Liquidity
Asset Allocation
| Asset | Percentage % |
|---|---|
| Bond | 93,42 % |
| NotClassified | 5,29 % |
| Cash | 1,29 % |
| Stock non-US | 0,00 % |
| Other | 0,00 % |
| Stock US | 0,00 % |
Largest Positions
| Symbol | ISIN | Name | Percentage % |
|---|---|---|---|
| BOEING CO SR UN.. | 2,84 % | ||
| BANK OF AMERICA.. | 2,77 % | ||
| AT+T INC SR UNS.. | 2,17 % | ||
| CREDIT SUISSE G.. | 1,94 % | ||
| MORGAN STANLEY .. | 1,91 % | ||
| STATE STREET IN.. | 1,86 % | ||
| BAT CAPITAL COR.. | 1,84 % | ||
| WELLS FARGO + C.. | 1,78 % | ||
| JPMORGAN CHASE .. | 1,77 % | ||
| ANHEUSER BUSCH .. | 1,71 % |
Region Distribution
| Region | Percentage % |
|---|---|
| Africa/Middle East | 0,00 % |
| Asia Developed | 0,00 % |
| Asia Emerging | 0,00 % |
| Australasia | 0,00 % |
| Europe Developed | 0,00 % |
| Europe Emerging | 0,00 % |
| Japan | 0,00 % |
| Latin America | 0,00 % |
| North America | 0,00 % |
| United Kingdom | 0,00 % |
Sector Distribution
| Sector | Percentage % |
|---|---|
| Grundstoffe | 0,00 % |
| Verbrauchsgüter | 0,00 % |
| Finanzdienstleistungen | 0,00 % |
| Immobilien | 0,00 % |
| Telekommunikation | 0,00 % |
| Energie | 0,00 % |
| Industrieunternehmen | 0,00 % |
| Technologie | 0,00 % |
| Basiskonsumgüter | 0,00 % |
| Gesundheitswesen | 0,00 % |
Company Profile for INTELGENX TECHNOLOGIES Share
IntelGenx Technologies Corp., a drug delivery company, focuses on the development and manufacturing of novel oral thin film products for the pharmaceutical market. It offers INT0008/2008, a Rizatriptan oral film product for the treatment of migraine; INT0046/2018 for adult use; INT0007/2006, an oral film product for treatment of erectile dysfunction; INT0043/2015, an oral film containing montelukast for treatment of Alzheimer; INT0027/2011 to treat opioid addition; INT0010/2006 for treatment of neuropathic pain and nausea in cancer patients undergoing chemotherapy; INT0036/2013, an oral film product for schizophrenia or bipolar 1 disorder; and INT0048/2020 for animal health. It is also developing INT0039/2013, INT0040/2014, INT0052/2020, INT0053/2020, and INT0054/2020. The company has licensing, development, and supply agreement with Tilray, Inc.; and development agreement with Cynapsus Therapeutics Inc. IntelGenx Technologies Corp. was founded in 2003 and is headquartered in Montreal, Canada.
Fund Master Data
Issuer Principal
Asset Class ETF
Name Principal Exchange-Traded Funds - Principal Investment Grade Corporate Active ETF
Fund Currency USD
Category Corporate Bond
Morningstar Rating 4
Fund Key Figures
Fund Size 486.880,38 EUR
Investment Strategy
The investment seeks to provide current income and, as a secondary objective, capital appreciation. The fund is an actively managed exchange-traded fund (ETF) that seeks to achieve its investment objective by investing, under normal circumstances, at least 80% of its net assets, plus any borrowings for investment purposes, in investment grade corporate bonds and other fixed income securities at the time of purchase. Investment grade securities are rated BBB- or higher by S&P Global Ratings (S&P Global) or Baa3 or higher by Moody's Investors Service, Inc. (Moody's) or, if unrated, of comparable quality in the opinion of those selecting such investments.
Company Data
Name INTELGENX TECHNOLOGIES
Company IntelGenx Technologies Corp.
Website
https://www.intelgenx.com
Primary Exchange 
TSX-V
TSX-V
WKN A0RP0X
ISIN US45822R1014
Asset Class Share
Sector Healthcare
Industry Biotechnology
CEO Dwight Gorham
Market Capitalization 42 Mio
Country Canada
Currency EUR
Employees -
Address 6420 Abrams, H4S 1Y2 Montreal
IPO Date 2008-05-27
Ticker Symbols
| Name | Symbol |
|---|---|
| TSX | IGX.TO |
More Shares
Investors who hold INTELGENX TECHNOLOGIES also have the following shares in their portfolio:
The financial platform MoneyPeak tracks and analyzes investments and portfolios.
From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.
